Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# 248.616: A Phase IV Randomised, Double-Blind, Active and Placebo-Controlled, 6-Week Trial to Investigate the Efficacy and Safety of a Starting (and Fixed) Dose 0.25 mg Pramipexole (Mirapex®) in Patients with Idiopathic Restless Legs Syndro
Zee, Phyllis C
(PD/PI)
Neurology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
1/10/07
→
9/30/08
Funding
Boehringer Ingelheim Pharmaceuticals, Inc.
(248.616)
View all
View less